Clinical Trials Directory

Trials / Unknown

UnknownNCT04902222

Orthostatic Intolerance and Hypotension After Administration of Morphine in Patients Prior to Hip or Knee Arthroplasty

Incidence of Orthostatic Intolerance and Orthostatic Hypotension After Administration of Intravenous Morphine in Patients Prior to Hip or Knee Arthroplasty

Status
Unknown
Phase
Study type
Observational
Enrollment
26 (estimated)
Sponsor
Copenhagen University Hospital, Hvidovre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Incidence of orthostatic intolerance and orthostatic hypotension after intravenous administration of morphine in patients prior to hip or knee arthroplasty.

Detailed description

Early postoperative mobilization is crucial for recovery of patients undergoing surgery in the multimodal fast-track approach to perioperative care, since physical immobilization is highly associated with increased risk of postoperative complications and prolonged hospital length of stay. Postoperative mobilization is often delayed due to patients experiencing orthostatic hypotension (OH), defined as a drop in systolic blood pressure \> 20 mmHg or diastolic blood pressure \> 10 mmHg, or orthostatic intolerance (OI), characterized by dizziness, blurred vision, nausea, vomiting, sensation of heat or syncope. Previous studies have found a high incidence of postoperative OI (\> 40 %) among patients undergoing total hip arthroplasty. A possible causative factor to the high occurrence of OH and OI after surgery could be postoperative pain management by administration of morphine. Morphine is known to have many side-effects including nausea, vomiting, dizziness and orthostatic hypotension. The object of this study is to isolate and estimate the effect of intravenous morphine on the incidence of OH and OI.

Conditions

Interventions

TypeNameDescription
DRUGMorphineAdministration of 0.1 mg/kg (IBW) intravenous morphine

Timeline

Start date
2021-04-01
Primary completion
2022-05-01
Completion
2022-05-01
First posted
2021-05-26
Last updated
2021-06-18

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04902222. Inclusion in this directory is not an endorsement.